Levesam 250 Eazy Glide Tablet contains Levetiracetam 250 mg, an antiepileptic medication used primarily for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit abnormal neuronal firing and reduce seizure activity. This formulation, designed for ease of swallowing, ensures patient compliance and consistent dosing. Levesam 250 is indicated as adjunctive therapy in adults and pediatric patients aged four years and above. It is well-absorbed orally, with rapid onset of action and minimal drug interactions, making it suitable for combination therapy with other antiepileptic drugs. Common adverse effects include somnolence, dizziness, fatigue, and behavioral changes such as irritability or agitation; however, it is generally well tolerated. Dose adjustments may be necessary in patients with renal impairment. Levesam 250 Eazy Glide Tablet should be used under medical supervision, with careful monitoring of seizure control and potential side effects. Patients are advised not to discontinue therapy abruptly to avoid increased seizure frequency.